aref al-kali, md, discusses the importance of specificity when selecting a flt3 inhibitor
Published 8 years ago • 22 plays • Length 0:42
Download video MP4
Download video MP3
Similar videos
-
2:02
aref al-kali, md, discusses the importance of sustained inhibition when selecting a flt3 inhibitor
-
0:44
aref al-kali, md, explains sustained inhibition of flt3 when treating aml patients
-
0:32
aref al-kali, md, regarding the leukostat test in conjunction with midostaurin
-
1:20
aref al-kali, md, on the data coming out of asco 2017 regarding flt3 mutant aml patients
-
0:55
aref al-kali, md, discusses the toxicity of the cpx-351 (vyxeos) in the phase iii study
-
1:10
aref al-kali, md, on how hematologists will adopt midostaurin for flt3 aml patients
-
1:44
aref al-kali, md, on immunotherapy and its potential role in treating hematological malignancies
-
1:14
alexander perl, md, discusses the potential impact of potency when selecting a flt3 inhibitor
-
11:06
how could new treatment options improve outcomes in flt3-mutated aml?
-
2:23
the significance of variant allele frequency in patients with sf3b1-mutated mds
-
6:43
flt3 mutations’ impact on prognosis and treatment in aml
-
0:41
aref al-kali, md, discusses cpx-351 (vyxeos) mechanism of action and why it is a promising agent
-
1:06
aref al-kali, md, reflects on the beat aml master trial and individualized therapy for aml patients
-
2:55
the importance of flt3 inhibitors in aml and factors to consider when choosing between these agents
-
1:32
aref al-kali, md, offers perspective on treating elderly aml patients
-
4:28
the rationale of flt3 inhibition in aml
-
0:58
dr. al-kali on fda approval of enasidenib in aml
-
1:12
the value of flt3 inhibitors in aml and focus for future trial designs
-
1:39
quantum-first: flt3-itd-specific mrd clearance is associated with improved os in newly diagnosed aml
-
2:54
aml17 trial update: flt3-itd mutation and daunorubicin dosage
-
1:03
targeted therapies in newly diagnosed aml: bcl2, flt3 and idh inhibitors
-
1:55
assessing flt3-itd-specific mrd clearance using a pcr-ngs assay in the quantum-first trial
Clip.africa.com - Privacy-policy